Back to Vontobel Holding Ltd. Vontobel Holding Ltd.

SGMOQ

Showing 8 of 23 quarters

Position history for Vontobel Holding Ltd.Vontobel Holding Ltd.'s holdings in SANGAMO THERAPEUTICS, INC

As of its Q1 2026 13F, Vontobel Holding held 120,000 shares of SGMOQ (Sangamo Therapeutics), worth $29,628. Vontobel Holding's 13F filings listed SGMOQ from Q4 2020 to Q1 2026, 22 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$259,380

Total Shares Change

-300,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.05
0
2026-Q1
Increased
120,000
+71.4%
$29,6280.0%$0.25
29
2025-Q4
Decreased
70,000
-32.2%
$29,4000.0%$0.42
0
2025-Q3
Increased
103,300
+40.9%
$69,5620.0%$0.67
28
2025-Q2
Increased
73,300
+25.7%
$39,6770.0%$0.54
25
2025-Q1
Decreased
58,300
-61.7%
$38,2330.0%$0.66
0
2024-Q4
Decreased
152,100
-49.3%
$155,1420.0%$1.02
0
2024-Q3
Increased
300,000
+412.3%
$259,3800.0%$0.87
37

Other major holders of SGMOQ: Wasatch Advisors LP, State Street Corp., Wellington Management Group LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used